MediPharm Labs Corp. (TSX:LABS)

Market Cap	31.56M
Revenue (ttm)	44.45M
Net Income (ttm)	-8.66M
Shares Out	420.76M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	160,111
Average Volume	373,109
Open	0.0700
Previous Close	0.0750
Day's Range	0.0700 - 0.0750
52-Week Range	0.0600 - 0.1200
Beta	0.41
RSI	45.49
Earnings Date	Aug 14, 2025

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 161
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2024, MediPharm Labs's revenue was 41.96 million, an increase of 26.92% compared to the previous year's 33.06 million. Losses were -10.69 million, -18.26% less than in 2023.